- Home
- SPRU vs RNAZ Comparison
SPRU vs RNAZ Comparison
Compare SPRU & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRU | RNAZ |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0M | 27.9M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SPRU | RNAZ |
|---|---|---|
| Price | $1.31 | $1.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 50.5K | 29.5K |
| Earning Date | 11-10-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.30 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $23,194,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $66.50 | ★ N/A |
| Revenue Growth | ★ 48.68 | N/A |
| 52 Week Low | $1.29 | $1.52 |
| 52 Week High | $6.75 | $12.60 |
Technical Indicators
Market Signals| Indicator | SPRU | RNAZ |
|---|---|---|
| Relative Strength Index (RSI) | 29.84 | 42.81 |
| Support Level | N/A | $1.57 |
| Resistance Level | $2.46 | $1.95 |
| Average True Range (ATR) | 0.06 | 0.16 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 9.09 | 21.95 |
Price Performance
Historical ComparisonAbout SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.